NL-OMON51881
Recruiting
Not Applicable
niversity Medical Centre Utrecht - National collaborative knowledge platform to impact on sex- and gender sensitive cardiovascular medicine - pilot - UMCU-IMPRESS pilot
niversitair Medisch Centrum Utrecht0 sites50 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- coronary vasculary dysfunction
- Sponsor
- niversitair Medisch Centrum Utrecht
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Patients referred for a coronary function test because of chronic angina,
- •defined as symptoms of angina at least 2 times a month despite medical therapy
- •for the last 3 months, in whom obstructive coronary artery disease was ruled
- •out by coronary computed tomography angiography or coronary angiography.
- •\- Patient is willing and able to provide written informed consent for
- •participation in this study
- •\- Patient is willing and able to provide written informed consent for blood
- •withdrawal and storage of blood in the biobank
Exclusion Criteria
- •\- Insufficient understanding and communication Dutch language.
- •\- No consent of the patient to participate in the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
trecht Health Project - Utrecht Cardiovascular Cohort (UHP-UCC)atherosclerosiscardiovascular disease100192801002914910003216NL-OMON55070niversitair Medisch Centrum Utrecht800
Not yet recruiting
Not Applicable
Validation of Skin Field Cancerisation Index: the assessment of a solar damage severity tool for patients undergoing radiotherapy treatment for field cancerisation.Skin Cancer including Keratinocyte CarcinomasSkin - Dermatological conditionsCancer - Malignant melanomaCancer - Non melanoma skin cancerACTRN12620000056998GenesisCare150
Active, not recruiting
Not Applicable
Cohorte multicentrique nationale de patients atteints de grippe pandémique(nouveau virus A/H1N1v d’origine porcine) - Etude Flu CoEUCTR2009-015100-25-FRINSERM1,500
Active, not recruiting
Phase 1
Clinical trial for the treatment of COVID-19 and COVID-like illness in primary careCOVID-19, COVID-like-illnessMedDRA version: 21.1Level: PTClassification code: 10068724Term: Antiviral treatment Class: 100000004865Therapeutic area: Diseases [C] - Virus Diseases [C02]CTIS2022-501707-27-01niversity Medical Center Utrecht1,001
Active, not recruiting
Not Applicable
Clinical trial for the treatment of COVID-19 and COVID-like illness in primary careReducing illness duration, complications, and possibly transmission of COVID-19 (SARS-CoV-2 infection) and other respiratory pathogensInfections and InfestationsISRCTN55471843niversity Medical Center Utrecht1,700